Insider trading · Q3 2026 · CIK 1091596

Nuo Therapeutics, Inc. (AURX) insider trading.

In Q3 2026, insiders at Nuo Therapeutics, Inc. reported 10 non-derivative transactions on 7 Forms 3, 4 and 5: 2 open-market purchases worth $10K and 0 sales.

Transactions
10
Purchases (P)
2
Sales (S)
0
Net shares, P minus S
8,773
Insiders
3
Last filed
2026-08-31

Insiders

InsiderRelationshipTransactionsBuysSales
Jorden David EmersonDirector, Officer · CEO/CFO620
Winzer C EricDirector200
Pittman Scott M.Director, TenPercentOwner200

Transactions

10 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-28Jorden David EmersonP (A)7,984$1.092,070,000Form 4/A
2026-08-28Jorden David EmersonA (A)7,984$1.092,070,000Form 4
2026-08-27Jorden David EmersonP (A)789$1.072,062,016Form 4/A
2026-08-27Jorden David EmersonA (A)789$1.072,062,016Form 4
2026-06-30Winzer C EricF (D)39,604$1.01173,050Form 4
2026-06-30Winzer C EricM (A)40,000$1212,654Form 4
2026-06-30Pittman Scott M.F (D)39,604$1.015,400,396Form 4
2026-06-30Pittman Scott M.M (A)40,000$15,440,000Form 4
2026-06-30Jorden David EmersonF (D)160,892$1.012,061,227Form 4
2026-06-30Jorden David EmersonM (A)162,500$12,222,119Form 4

Transaction codes in this quarter

Get AURX insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1091596&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · AURX company page · Nuo Therapeutics, Inc. on SEC.gov

Questions

Are insiders buying or selling Nuo Therapeutics, Inc. (AURX)?

In Q3 2026, insiders at Nuo Therapeutics, Inc. reported 10 non-derivative transactions on 7 Forms 3, 4 and 5: 2 open-market purchases worth $10K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Nuo Therapeutics, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/aurx.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.